You are here

  • Home
  • Archive
  • Volume 79, Issue 8
  • Response to: ‘Differentiating disease activity from damage in systemic sclerosis: it’s still early days!’ by Jain and Sharma

Article Text

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Differentiating disease activity from damage in systemic sclerosis: it’s still early days!’ by Jain and Sharma
Free
  1. Mandana Nikpour
  2. On behalf of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) Working Group
  1. Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia
  1. Correspondence to Dr Mandana Nikpour, Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia; m.nikpour{at}unimelb.edu.au

https://doi.org/10.1136/annrheumdis-2019-215639

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Drs Jain and Sharma1 for their interest in our work.2 We agree that what may be deemed irreversible loss of organ structure and/or function in the current therapeutic landscape of systemic sclerosis (SSc), may one day be reversible and indeed even preventable as highly effective novel therapies become available.

    We caution against the erroneous interpretation …

    View Full Text

    Linked Articles